{
  "trial_id": "NCT02340520",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Established diagnosis of COPD with FEV1 <60% predicted",
      "label": "met",
      "evidence": "Spirometry was performed revealing a forced expiratory volume in the first second (FEV1) of 63% of the predicted."
    },
    {
      "criterion": "Patients of both genders will be included",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "IRB approved written informed consent will be obtained from each subject",
      "label": "met",
      "evidence": ""
    }
  ],
  "exclusion": [
    {
      "criterion": "Recent (<1 month) exacerbation of COPD",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Known hypersensitivity to beta agonists, theophylline, steroids, or roflumilast",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Current or recent (<2 weeks) treatment with oral steroids, theophylline or other methylxanthines, or roflumlast",
      "label": "not_met",
      "evidence": ""
    }
  ],
  "notes": "The patient has a history of asthma for 3 years, but his symptoms improve within 1-2 hours outside the workplace. He currently uses inhaled corticosteroid (ICS) and fluticasone 500 mcg/salmeterol 50 mcg.",
  "_meta": {
    "topic_id": "23",
    "trial_id": "NCT02340520",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}